Medications

Calcium channel blockers may improve chemotherapy response

Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National Academy of Sciences.

Oncology & Cancer

Know your risk for hereditary cancer

Most people have at least one extended family member who has had cancer. But does that put you at a higher risk for developing cancer? Baylor College of Medicine genetic counselor Tanya Eble explains the risk factors for ...

Medical research

Exploring a novel treatment for K-Ras mutant pancreatic tumors

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. The K-Ras mutant pancreatic cancer is one of the most common types. At present, there are no effective ...

Oncology & Cancer

New guidelines for pancreatic cancer screening

By the year 2030, pancreatic cancer is expected to become the second most common cause of cancer deaths for both men and women in the United States, according to recent reports. While considered uncommon, inherited gene mutations ...

page 1 from 40

Pancreatic cancer

Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.

This text uses material from Wikipedia, licensed under CC BY-SA